Evidence map›Paper›PMID 26678270›Full record

GuidelineEuropean journal of nuclear medicine and molecular imaging2016

Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis.

Jan Bucerius, Fabien Hyafil, Hein J Verberne, Riemer H J A Slart, Oliver Lindner, Roberto Sciagra, Denis Agostini, Christopher Übleis, Alessia Gimelli, Marcus Hacker and 1 more

Registry-linked trialOpen access · hybridAbstract readGuideline
In one paragraph

Guideline in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04046237 (Impact of Treating Severe Periodontitis on Inflammatory Activity of Atheromatous Plaques in Patients With Acute Myocardial Infarction), which is not on this map. Cited by 152 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 4 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04046237 narecruitingnot on this mapstarted 2019, after this paper: background citation

Impact of Treating Severe Periodontitis on Inflammatory Activity of Atheromatous Plaques in Patients With Acute Myocardial Infarction (AMI)

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2019 to 2028Enrolled210ConditionsAcute Myocardial Infarction, Severe Periodontitis, Carotid AtherosclerosisArmsPeriodontal treatment
3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 4 syntheses or guidelines pooled it, 249 citations in OpenAlex.

  1. Vascular medicine (London, England) · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2018
    Pooled it
  5. Trial
  6. Trial
  7. Effect of Liraglutide on Arterial Inflammation Assessed as [Circulation. Cardiovascular imaging · 2021
    Trial
  8. Trial
  9. PulmonaryEuropean journal of nuclear medicine and molecular imaging · 2018
    Trial
  10. Detection of Atherosclerotic Inflammation byJournal of the American College of Cardiology · 2017 · on this map
    Trial
  11. Article
  12. Association of Atherosclerosis [Molecular imaging and biology · 2026
    Article
  13. Delayed total-body [European journal of nuclear medicine and molecular imaging · 2026
    Article
  14. Cardiovascular imaging with total-body PET.The British journal of radiology · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. From incidental positron emission uptake toFrontiers in cardiovascular medicine · 2026
    Review
  19. Review
  20. Feasibility of [Diagnostics (Basel, Switzerland) · 2025
    Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 5 countries.

Jan BuceriusDepartment of Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands. jan.bucerius@mumc.nl.
Fabien HyafilDepartment of Nuclear Medicine, Bichat University Hospital, Inserm 1148, DHU FIRE, Assistance Publique - Hôpitaux de Paris, Paris, France.
Hein J VerberneDepartment of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Riemer H J A SlartDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Oliver LindnerNuclear Medicine and Molecular Imaging, Institute of Radiology, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany.
Roberto SciagraNuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Denis AgostiniDepartment of Nuclear Medicine, CHU Côte de Nacre, Normandie Université, Caen, France.
Christopher ÜbleisDepartment of Clinical Radiology, Ludwig-Maximilians Universität München, München, Germany.
Alessia GimelliFondazione Toscana Gabriele Monasterio, Pisa, Italy.
Marcus HackerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided therapy, Medical University Vienna, Vienna, Austria.
Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)
Centre Hospitalier Universitaire de Caen · FRFondazione Toscana Gabriele Monasterio · ITHeart and Diabetes Center North Rhine-Westphalia · DELudwig-Maximilians-Universität München · DEMaastricht University · NLMedical University of Vienna · ATTechnical University of Munich · DEUniversity Medical Center Groningen · NLUniversity of Amsterdam · NLUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases are the leading cause of death not only in Europe but also in the rest of the World. Preventive measures, however, often fail and cardiovascular disease may manifest as an acute coronary syndrome, stroke or even sudden death after years of silent progression. Thus, there is a considerable need for innovative diagnostic and therapeutic approaches to improve the quality of care and limit the burden of cardiovascular diseases. During the past 10 years, several retrospective and prospective clinical studies have been published using (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) to quantify inflammation in atherosclerotic plaques. However, the current variety of imaging protocols used for vascular (arterial) imaging with FDG PET considerably limits the ability to compare results between studies and to build large multicentre imaging registries. Based on the existing literature and the experience of the Members of the European Association of Nuclear Medicine (EANM) Cardiovascular Committee, the objective of this position paper was to propose optimized and standardized protocols for imaging and interpretation of PET scans in atherosclerosis. These recommendations do not, however, replace the individual responsibility of healthcare professionals to make appropriate decisions in the circumstances of the individual study protocols used and the individual patient, in consultation with the patient and, where appropriate and necessary, the patient's guardian or carer. These recommendations suffer from the absence of conclusive evidence on many of the recommendations. Therefore, they are not intended and should not be used as "strict guidelines" but should, as already mentioned, provide a basis for standardized clinical atherosclerosis PET imaging protocols, which are subject to further and continuing evaluation and improvement. However, this EANM position paper might indeed be a first step towards "official" guidelines on atherosclerosis imaging with PET.

Indexed as

AtherosclerosisHumansPositron-Emission TomographyRadiopharmaceuticalsRadiopharmaceuticalsAtherosclerosisPosition paperPositron emission tomography

Identifiers

PMID26678270
PMCPMC4764627
OpenAlexW2212351890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.